Kintor Pharmaceutical Ltd. has announced changes to its Nomination Committee effective June 26, 2025. Dr. Youzhi Tong has stepped down as chairman and member of the committee. Ms. Geqi Wei has been appointed as a member, and Dr. Michael Min Xu is now the chairman. The committee now includes two independent non-executive directors and one non-executive director, enhancing its diversity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.